Preparation and in vitro characterization of the transdermal drug delivery system containing tamoxifen citrate for breast cancer

Main Article Content

Anjana Adhyapak
Desai BG


A matrix-type transdermal drug delivery system of tamoxifen citrate was developed by using a different ratio of eudragit- RL100, hydroxypropyl methyl cellulose (HPMC-K15), and ethyl cellulose (EC), by the solvent evaporation technique.The effect of the binary mixture of polymers with a penetration enhancer on the physical chemical parameters including, thickness, folding endurance, uniformity of drug content, moisture content, moisture uptake, tensile strength, and in vitro drug permeation were evaluated. The in vitro drug permeation studies were conducted by using modified Keshary-Chein diffusion cells through female Sprague Dawley rat skin using pH 7.4 phosphate buffer saline (PBS).The selected formulation’s
stability studies were conducted as per the International Conference on Harmonization (ICH) guidelines, and did not show
any degradation of the drug.


Download data is not yet available.

Article Details

How to Cite
Adhyapak, A., & BG, D. (2014). Preparation and in vitro characterization of the transdermal drug delivery system containing tamoxifen citrate for breast cancer. Asian Journal of Pharmaceutics (AJP), 5(1).


Barry BW. Novel mechanisms and devices to enable successful

transdermal drug delivery. Eur J. Pharm Sci 2001;14:101-14.

Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug

Deliv Rev 2004;56:581-87.

Schuetz YB, Naik A, Emerging strategies for the transdermal delivery

of peptide and protein drugs. Expert Opin Drug Deliv 2005;2:533-48.

Memisoglu-Bilensoy E, Vural I, Bochot A, Renoir JM, Duchene D,

Hıncal AA. Tamoxifen citrate loaded amphiphilic β-cyclodextrin

nanoparticles: In vitro characterization and cytotoxicity. J Control

Release 2005;104:489-96.

Gao S, Singh J. In vitro percutaneous absorption enhancement of a

lipophilic drug tamoxifen by terpenes. J Control Release 1998;51:193-199.

Shin S, Choi J, Li X. Enhanced bioavailability of tamoxifen after

oral administration of tamoxifen with quercetin in rats. Int J Pharm


Arora P, Mukherjee B. Design, development, physicochemical and

in vitro and in vivo evaluation of transdermal patches containing

diclofenac diethyl ammonium salt. J Pharm Sci 2002;91:2076-89.

Wade Hull MS. Heat-enhanced transdermal drug delivery: A survey

paper. J Appl Res 2002;2:1-9.

Indian pharmacopoeia.2007. Ministry of Health and Family Welfare

Government of India, 2007. p. 1779.

Ritschel WA, Hussain AS. The principles of permeation of substance

across the skin. Methods Find. Exp Clin Pharmacol 1988;10:39-56.

Kaidi Z, Singh J. In vitro percutaneous absorption enhancement of

propranolol hydrochloride through porcine epidermis by terpenes /

ethanol. J Control Release 1999;62:359-66.

Rowe RC, Sheskery PJ. Weller PJ. Hand book of pharmaceutical excipient,

th ed. London: Pharmaceutical Press Publishers; 2003. P. 2115.

Mutalik S, Udupa N. Glibenclamide transdermal patches:physicochemical,

pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci


Mukherjee B, Mahapatra S, Gupta R, Patra B, Tiwari A, Arora P.

A comparison of povidone-ethylcellilose and povidone-eidragit

transdermal dexamethasone matrix patches based on in vitro skin

permeation. Eur J Pharm Biopharm 2005;59:475-483.

Ubaidulla U, Reddy MVS, Ruckmani K, Ahmad FJ, Khar RP. Transdermal

therapeutic system of carvedilol: effect of hydrophilic and hydrophobic

matrix on in vitro and in vivo characteristics. AAPS PharmSciTech


Sadashivaiah R, Dinesh BM, Desai BG, Raghu KS. Design and in vitro

evaluation of halperidol lactate transdermal patches containing ethyl

cellulose-povidone as film formers. Asian J Pharm 2008;4:43-49.

Limpongsa E, Umprayn K. Preparation and evaluation of diltiazem

hydrochloride diffusion-controlled transdermal delivery system. AAPS

PharmSciTech 2008;9(2):464-70.

Fischer W, Klokkers K, Sendl-Lang, A. Transdermal system in the form of

a patch comprising a tamoxifen derivative. US Patent 5,904,939;1999.